Platinum‐based chemotherapy for early triple‐negative breast cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Platinum‐based Chemotherapy for Early Triple‐negative Breast Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431354/all/Platinum‐based_chemotherapy_for_early_triple‐negative_breast_cancer. Accessed 24 September 2023.
Platinum‐based chemotherapy for early triple‐negative breast cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431354/all/Platinum‐based_chemotherapy_for_early_triple‐negative_breast_cancer. Accessed September 24, 2023.
Platinum‐based chemotherapy for early triple‐negative breast cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431354/all/Platinum‐based_chemotherapy_for_early_triple‐negative_breast_cancer
Platinum‐based Chemotherapy for Early Triple‐negative Breast Cancer [Internet]. In: Cochrane Abstracts. [cited 2023 September 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431354/all/Platinum‐based_chemotherapy_for_early_triple‐negative_breast_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Platinum‐based chemotherapy for early triple‐negative breast cancer
ID - 431354
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431354/all/Platinum‐based_chemotherapy_for_early_triple‐negative_breast_cancer
DB - Evidence Central
DP - Unbound Medicine
ER -